High-Dose Dexamethasone for Nausea and Vomiting in Lung Cancer Patients
Author Information
Author(s): I Sekine, Y Nishiwaki, R Kakinuma, K Kubota, F Hojo, T Matsumoto, H Ohmatsu, M Yokozaki, K Goto, T Miyamoto, J Takafuji, T Kodama
Primary Institution: National Cancer Center Hospital East
Hypothesis
Can high-dose dexamethasone effectively control acute and delayed nausea and vomiting in lung cancer patients receiving cisplatin?
Conclusion
High-dose dexamethasone combined with metoclopramide resulted in total control of nausea and vomiting in about half of the patients treated with cisplatin.
Supporting Evidence
- 85% of patients had no nausea or vomiting on day 1.
- 48% of patients achieved total control of nausea and vomiting over five days.
- Patients were aged between 15 and 74 years.
- High-dose dexamethasone was administered over five days.
Takeaway
This study tested a strong medicine to help cancer patients not feel sick after treatment, and it worked for many of them.
Methodology
Patients with lung cancer receiving cisplatin were treated with high-dose dexamethasone and other antiemetics, and their responses were recorded over five days.
Limitations
The study had a small sample size and did not include patients with certain health conditions.
Participant Demographics
The study included 33 patients, 12 (36%) were female, and 18 (55%) were under 60 years old.
Statistical Information
Confidence Interval
95% CI: 32.5-64.8%
Want to read the original?
Access the complete publication on the publisher's website